Therefore, we hypothesize that LE strongly regulates the Nrf2/ARE/anti-oxidative stress signaling pathways, phase II detoxifying enzymes and drug transporter induction, which would contribute to pharmacological effects that promote overall health and inhibit diseases, including cancer. Here, NFE2L2 is linked to cancer.